Provided by Tiger Fintech (Singapore) Pte. Ltd.

MetaVia Inc

0.7051
-0.0316-4.30%
Post-market: 0.70510.00000.00%19:58 EDT
Volume:58.51K
Turnover:40.99K
Market Cap:13.81M
PE:-0.26
High:0.7300
Open:0.7251
Low:0.6807
Close:0.7367
Loading ...

MetaVia doses first patient in 48 mg MAD cohort of its Phase 1 trial

TIPRANKS
·
09 Jul

Metavia Inc. Doses First Patient in 48 mg Cohort of Phase 1 Trial for Obesity Drug DA-1726, Top-Line Data Expected by End of 2025

Reuters
·
09 Jul

Metavia Inc - Top-Line Data Expected in Q4 2025

THOMSON REUTERS
·
09 Jul

Metavia Doses First Patient in the 48 Mg Mad Cohort of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity to Further Explore Maximum Tolerated Dose

THOMSON REUTERS
·
09 Jul

Metavia Files Prospectus for Investors to Sell 14.1 Million Shares

MT Newswires Live
·
03 Jul

BRIEF-Metavia Files For Resale Of Up To 14.1 Million Shares Of Common Stock By Selling Securityholders

Reuters
·
03 Jul

MetaVia files to sell 14.08M shares of common stock for holders

TIPRANKS
·
03 Jul

Metavia Inc Files for Resale of up to 14.1 Mln Shares of Common Stock by Selling Securityholders - SEC Filing

THOMSON REUTERS
·
03 Jul

Metavia Inc. Conducted Virtual Annual Stockholders Meeting

Reuters
·
01 Jul

MetaVia announces presentation of pre-clinical data on DA-1241

TIPRANKS
·
23 Jun

Metavia Inc - Combination Therapy Decreases Inflammatory and Fibrotic Gene Expression

THOMSON REUTERS
·
21 Jun

Metavia Presents Pre-Clinical Data on Da-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the Ada's 85TH Scientific Session

THOMSON REUTERS
·
21 Jun

MetaVia Inc. Announces Promising Pre-Clinical Data on DA-1241 with Efruxifermin Combination for MASH Treatment at ADA's Scientific Session

Reuters
·
21 Jun

Metavia Inc. CFO Marshall H. Woodworth Reports Acquisition of Common Shares

Reuters
·
05 Jun

Metavia Inc. Faces Nasdaq Delisting Risk Due to Sub-$1 Stock Price

Reuters
·
31 May

Metavia Inc. Unveils Presentation on Innovative Cardiometabolic Therapies Targeting Obesity and MASH

Reuters
·
21 May

Dong-A ST Co., Ltd Acquires Common Shares of Metavia Inc

Reuters
·
21 May

MetaVia Is Maintained at Buy by Maxim Group

Dow Jones
·
20 May

MetaVia price target lowered to $3 from $6 at Maxim

TIPRANKS
·
19 May

Maxim Group Sticks to Its Buy Rating for MetaVia (MTVA)

TIPRANKS
·
17 May